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Background: Binge ethanol in rats after chronic ethanol exposure augments necrosis and steatosis in the liver. In
this study, two-dimensional gel electrophoresis proteomic profiles of liver of control, chronic ethanol, control-binge,
and chronic ethanol- binge were compared.
Results: The proteomic analysis identified changes in protein abundance among the groups. The levels of carbonic
anhydrase 3 (CA3) were decreased after chronic ethanol and decreased further after chronic ethanol-binge. Ethanol
binge alone in control rats had no effect on this protein suggesting its possible role in increased susceptibility to
injury by binge after chonic ethanol treatment. A protein spot, in which both cytosolic isocitrate dehydrogenase
(IDH1) and glutamine synthetase (GS) were identified, showed a small decrease after chronic ethanol binge but
western blot demonstrated significant decrease only for glutamine synthetase in chronic ethanol treated rats. The
level of gluathione S-transferase mu isoform (GSTM1) increased after chronic ethanol but was lower after chronic
ethanol-binge compared to chronic ethanol treatment. The protein levels of the basic form of protein disulfide
isomerase associated protein 3 (PDIA3) were significantly decreased and the acidic forms were increased after
chronic ethanol- binge but not in chronic ethanol treated rats or ethanol binge in control rats. The significant
changes in proteome profile in chronic ethanol binge were accompanied by a marked increase in liver injury as
evidenced by enhanced steatosis, necrosis, increased 4-hydroxynonenal labeled proteins, CYP2E1 expression, and
decreased histone H2AX phosphorylation.
Conclusions: Given the role of CA3, IDH1 and GST in oxidative stress; PDIA3 in protein quality control, apoptosis
and DNA repair and decreased glutamine synthetase as a sensitive marker of pericentral liver injury this proteome
study of chronic ethanol-binge rat model identifies these proteins for the first time as molecular targets with
potential role in progression of liver injury by binge ethanol drinking.
Keywords: Binge ethanol, Chronic ethanol, Liver proteomicsBackground
Alcoholic liver disease is a worldwide health problem [1,2].
The mechanisms that cause progression of liver injury are
complex. Healthy liver is resistant to the action of ethanol
and most individuals consuming alcohol have steatosis but
not steatohepatitis [3]. The progression of steatosis to stea-
tohepatitis has been shown to be dependent on additional
factors such as endotoxin, nutritional factors, and other
disease states such as hepatitis C viral infection [4-7]. In
this regard, binge drinking habit in chronic alcoholics is
one of the most important factors contributing to the* Correspondence: shuklasd@missouri.edu
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reproduction in any medium, provided the orprogression of alcoholic liver injury [8-11]. We have
recently developed a chronic ethanol-binge rat model in
which short term chronic ethanol treatment for 4 weeks
does not result in significant liver injury. When these rats
were subjected to 3 episodes of repeat ethanol binge it dra-
matically amplified liver injury. This rat model mimics
findings similar to humans particularly during early alco-
holic liver injury [12]. Therefore, it offers an opportunity
to determine the effects of binge after chronic ethanol in-
take and to explore the underlying mechanisms of
enhancement of liver injury by binge ethanol.
Recent developments of systems biology approaches
including genomics, metabolomics and proteomics offer
a better insight into the mechanisms of cellular injury
and identification of protein targets without a priortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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[13]. Although gene expression has provided valuable in-
formation on transcriptional regulation, significant dis-
crepancy occurs between changes in RNA and protein
expression since not all expressed genes are translated
into protein products [14]. Two dimensional electro-
phoresis in combination with mass spectrometry (2DE-
MS), has been widely applied for the analyses of protein
expression and their post translational modifications
[15]. Proteome studies on liver have been useful in eluci-
dating the biomarkers of liver damage and factors that
contribute to susceptibility of liver tissue to drug or
disease induced liver injury [14-16]. Although, liver
proteomic studies have been reported for chronic etha-
nol treated rats [17-22], proteomics after ethanol binge
drinking has not been examined. We have therefore
undertaken a 2-dimensional (2D) gel-based proteomics
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Figure 1 Composite images of 2D gels of proteins extracted from live
binge treated rats. Rats were fed ethanol in liquid diet chronically for 4 w
Four hours after the last dose liver samples were frozen in liquid nitrogen a
and methanol/ammonium acetate precipitation and 2D electrophoresis and
Figure 1 represents a composite image of the gel and the proteins that are
protein sequenced are shown by spot numbers. Control represents pair –fe
group.Results
Chronic ethanol, control-binge and chronic ethanol-binge
display differential expression of proteins
Rats were divided into four groups: control (pair-fed isoca-
loric diet), chronic ethanol (4 weeks), control-binge (pair-
fed followed by 3 ethanol binge), and chronic ethanol-
binge (chronic ethanol 4 weeks followed by 3 binge). Three
samples from each group were included for proteome ana-
lysis. Figure 1 shows representative 2D gel maps of liver
proteins obtained from four groups. A total of 600–725
spots were resolved on these Coomassie Brilliant Blue
(CBB) stained 2D gels. Spot volumes (area x intensity)
were determined as a measure of protein expression. Spots
that showed 1.5 fold increase or decrease were included
in the analysis and proteins that are present in appre-
ciable amounts were picked for identification by mass
spectrometry (Figure 1).
Eight proteins that were affected by either chronic
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r of control, chronic ethanol, control-binge, and chronic ethanol-
eeks and then given three ethanol binges (5 g/kg) at 12 hr intervals.
nd stored for proteome studies. Proteins were extracted by phenol
analysis were performed as described under Materials and Methods.
differentially expressed between the treatment groups and the
d animals that were given water for binge control. N = 3 rats for each
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digested with trypsin, and subjected initially to MALDI-
TOF/TOF MS+MS/MS analysis. Protein identification
by MALDI-TOF/TOF was subsequently confirmed by
peptide sequences obtained by acquiring multiple LC/
MS/MS spectra for each sample. The results are shown
in Table 1. Spots 63 & 64 were identified as carbonic
anhydrase 3 (CA3) and spots 116, 117, 120 & 123 were
identified as isoforms of protein disulfide isomerase asso-
ciated protein 3 (PDIA3). Spot 213 contained two pro-
teins identified as cytosolic isocitrate dehydrogenase
(IDH1) and glutamine synthetase (GS). Spot 53 was
identified as glutathione S transferase, mu form
(GSTM1).
The levels of CA3 decreased after chronic ethanol
(Figure 2). Its levels decreased further after chronic
ethanol followed by binge . In the control-binge group,
CA3 levels were not significantly changed suggesting its
role in increased injury by binge ethanol in chronic
ethanol treated rats. We have also determined protein
levels of CA3 by western immunoblot (Figure 2). The
results were in agreement with the proteomic analysis.
The spot volume representing combined protein levels of
cytosolic isocitrate dehydrogenase/glutamine synthetase inTable 1 Identification of differentially expressed protein
spots by mass spectrometry











3137484 29698 206 7
64 Carbonic
anhydrase 3
3137484 29698 505 12
213 Cytosolic isocitrate
dehydrogenased
6647554 47030 202 10
213 Glutamine
synthetased
204349 43001 133 5
53 Glutathione S
transferase M1
204503 26127 674 17
116 Protein disulfide
isomerase A3
1352384 57044 163 6
117 Protein disulfide
isomerase A3
1352384 57044 797 22
120 Protein disulfide
isomerase A3
1352384 57044 994 28
123 Protein disulfide
isomerase A3
1352384 57044 1294 30
aData from LCMS runs were searched against NCBInr limited to mammals
using MASCOT V2.2.
bThis is the predicted molecular weight based on the translated gene
sequence.
cThe total ion score from the MASCOT report. Individual peptide ion scores
>36 have significant identify or homology (p< 0.05).
dTwo proteins were confidently identified in spot number 213. Based on
number of peptides matched, isocitrate dehydrogenase is likely the more
abundant of the two.proteome analysis was decreased by about 40% after
chronic ethanol–binge (Figure 3). However, the western
blot results showed only a small decrease in the protein
levels of cytosolic IDH1 in all the treated groups. Interest-
ingly, protein levels of glutamine synthetase decreased in
the chronic ethanol-binge group (Figure 3). In the
proteome analysis, GSTM1 levels were increased after
chronic ethanol and control binge but the levels are
lower in chronic ethanol-binge compared to chronic
ethanol (Figure 4). However, western immunoblot did
not reveal significant increase after chronic ethanol
(Figure 4). PDIA3 was identified in multiple forms with
shifting of isoelectric point (pI). The protein levels of
the more basic forms (spots 120 and 123) were lower in
the chronic ethanol binge group whereas the protein
levels of the more acidic forms (spots 116 and 117)
were higher in the chronic ethanol binge group
(Figure 5). The western immunoblot did not reveal any
significant change in the expression of PDIA3 in any of
the groups (Figure 5). We therefore calculated the sum
of the density of all the forms in proteome analysis and
observed that the changes in all the three treated
groups were not different from the control group (data
not shown). These results suggest that, changes in the
levels of different isoforms seen after chronic-ethanol
binge may represent post translational modifications of
the protein. The shift in charge may be due to phos-
phorylation of PDIA3 forms since phosphorylation of
PDIA3 has been shown to occur in vivo and such
alterations are associated with a decrease in protein
folding function of PDIA3 [23]. To examine this possi-
bility, we performed pro-Q staining that detects phos-
phorylated forms. Pro Q stain showed significant
decrease and increase in several phosphorylated pro-
teins (Figure 6). However, the phosphorylation status of
those proteins that showed differential changes in Coo-
massie blue staining (Table 1) were not altered. It may
be mentioned that the quantitative analysis of these
phosphorylated spots showed a trend for lowered phos-
phorylation for basic forms of PDIA3 and increased
phosphorylation for acidic form (data not shown).
Relationship of proteome changes to liver injury during
chronic ethanol and chronic ethanol-binge
CA3 and IDH1 have been shown to exert protection
against oxidative stress and liver injury [24,25]. We exam-
ined hepatic steatosis in different groups. The results are
shown in Figure 7 A-D. Steatosis was moderate in the
chronic ethanol group or control ethanol binge. In con-
trast, stetaosis was more marked in chronic ethanol binge
group. Another parameter of hepatotoxic effects of alcohol
is increased expression of CYP2E1 [26,27]. Compared to
control, a moderate increase (1.5 to 2 fold) in CYP2E1
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Figure 2 Quantitative analysis of carbonic anhydrase 3 isoforms from 2D gels and western immunoblot analysis. Rats were fed ethanol
in liquid diet chronically for 4 weeks and then given 3 binge (5 gm/kg) at 12 hr intervals and samples were collected as in Figure 1. The levels of
carbonic anhydrase 3 were determined by western immunoblot as described under Materials and Methods. Control represents pair –fed animals
that were given water for binge control. Values are mean± SE (n = 3 rats for each group). Western blot represents a typical experiment.
*significant from control group (p< 0.05); C: Control (pair fed); E: Chronic ethanol; C-B: Control- ethanol binge; E-B: Chronic-ethanol binge.
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fold) in CYP2E1 was seen after chronic ethanol-binge
(Figure 7E). We have also determined the pattern of pro-
tein oxidation using antibodies against 4-hydroxynonenalControl Chronic-ethanol
Proteome analysis
C    E    C-B  E-B C    E    C-B
Figure 3 Quantitative analysis of cytosolic isocitrate dehydrogenase a
analysis. Rats were fed ethanol in liquid diet chronically for 4 weeks and th
levels of isocitrate dehydrogenase and glutamine synthetase were determin
given water for binge control. Values are mean± SE (n = 4 rats). Western blo
(p< 0.05); C: Control (pair fed); E: Chronic ethanol; C-B: Control- ethanol bin(4-HNE). The increase in 4-HNE is not only an index of
cellular oxidative stress but also suggestive of altered func-
tion of oxidatively modified proteins [28-30]. A represen-
tative western blot is shown in Figure 7F. Chronic ethanolControl-binge Chronic ethanol-
binge
Western analysis
  E-B  C    E    C-B  E-B
*
nd glutamine synthetase from 2D gels and western immunoblot
en given 3 binge of ethanol and samples collected as in Figure 1. The
ed by western immunoblot. Control represents pair –fed animals
t represents a typical experiment. *significant from control group
ge; E-B: Chronic-ethanol binge.
Control Chronic-ethanol Control-binge Chronic ethanol-
binge
Proteome analysis Western analysis
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Figure 4 Quantitative analysis of glutathione S-transferase M1 from 2D gels and western immunoblot analysis. Rats were fed ethanol in
liquid diet chronically for 4 weeks and then given 3 binges before sample collection as detailed in Figure 1. The levels of glutathione transferase
mu were determined by western immunoblot. Control represents pair –fed animals that were given water for binge control. Values are mean± SE
(n = 3 rats for each group). Western blot represents a typical experiment. *significant from control group (p< 0.05); C: Control (pair fed); E: Chronic
ethanol; C-B: Control- ethanol binge; E-B: Chronic-ethanol binge.
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low molecular weight whereas increases in 4-HNE staining
of high molecular weight proteins were seen in the control
binge group. In chronic ethanol–binge group there was an
increase in 4-HNE staining of low molecular weight as
well as of high molecular weight bands demonstrating
increased oxidative stress in this group. Consistent with
this pattern is the observation that CA3 protein levels
decreased in the chronic ethanol group and further de-
crease in the chronic ethanol-binge (Figure 2). In the
chronic ethanol, or control-binge groups a moderate in-
crease in transaminase levels was noted. Its levels
increased significantly in the ethanol- binge group suggest-
ing augmentation of liver injury (Figure 7G). Recent studies
have shown proapototic role for PDIA3 . This was sup-
ported by a decrease in PDIA3 expression and caspase 3
levels [31]. To examine this in our model we determined
the expression of cleaved caspase 3 in different groups of
ethanol treatment (Figure 7H). Cleaved caspase 3 levels
decreased in the chronic ethanol binge. We also examined
the relevance of PDIA3. PDIA3 has been implicated in the
modulation of histone H2AX phosphorylation. Decreased
expression of PDIA3 by siRNA silencing resulted in
decreased phosphorylation of H2AX [32]. Since H2AX
phosphorylation has been implicated in DNA repair, we
therefore examined histone H2AX phosphorylation in the
four treatment groups. Histone H2AX phosphorylationwas significantly decreased in the chronic-ethanol binge
group (Figure 7I).
Discussion
This is the first proteomic study of global alterations of
proteins in liver from chronic ethanol-binge treated ani-
mals. The chronic ethanol binge model developed in this
laboratory displays a number of features that are seen
during human alcoholic liver injury (12). Therefore this
model is useful for the investigation of the mechanism of
binge induced enhancement of alcoholic liver injury.
Using a proteomics approach, we have demonstrated
changes in the levels of a number of liver proteins
affected differentially by chronic ethanol, control-binge
and chronic ethanol-binge. A notable aspect of this study
is the identification of these protein targets in a single
model. Previously these protein targets have been
reported individually in separate studies. The fact that
normal liver is resistant to acute ethanol binge [12] as
seen in control-binge group in this study, we propose
that the increased vulnerability to binge after chronic
ethanol treatment and the accompanying alterations in
proteins contribute to the amplification of injury.
We find a marked decrease in CA3 in chronic ethanol
but not control-binge treated rats. Decrease in CA3 pro-
tein level after chronic ethanol administration has been
reported [19], but the effects of acute ethanol binge or
Control Chronic ethanol Control-binge Chronic ethanol- 
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Figure 5 Quantitative analysis of PDIA3 from 2D gels and western immunoblot analysis. Sample preparations were similar to that in
Figure 1. The upper panel shows 2D proteome profile of the 4 treatment groups (see Figure 1). The spots (# 116, 117, 120 & 123) were quantified
and data are presented in the histograms (middle panel). The bottom panel shows western immunoblot using antibody for PDIA3 in the four
group samples. Values are mean± SE (n = 3 rats for each group). Western blot represents a typical experiment. *significant from control group
(p< 0.05); C: Control (pair fed); E: Chronic ethanol; C-B: Control- ethanol binge; E-B: Chronic-ethanol binge.
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In another study, chronic ethanol treatment in rats
decreased carbonic anhydrase mRNA levels [33] suggesting
that the regulation of CA3 occurs at the level of transcrip-
tion. CA3 is an enzyme that has negligible carbonic anhy-
drase activity compared to other isoforms of carbonic
anhydrase [34]. It has been proposed to have a cytoprotec-
tive action against oxidative stress. In NIH/3T3 cells over-
expressing CA3, steady state levels of reactive oxygen spe-
cies are reduced and these cells were protected against
hydrogen peroxide induced oxidative stress [35]. CA3 has
also been shown to undergo reversible S-thiolation reac-
tions with glutathione and reversible glutathiolation has
been proposed to provide protection to the reactive
cysteine residues in proteins from damaging oxidative
reactions [36]. This assumes significance from studies
supporting antioxidant role of CA3. A decrease in CA3 in
the present study and augmentation of liver injury as
demonstrated by increased transaminase favors the view
that it has a protective role. Moreover, lipid peroxidation
and oxidative stress has been shown to be increased in an
experimental model of chronic ethanol followed by
intraperitoneal administration of ethanol binge [37]. In
the present study, we observed a marked decrease in
CA3 levels in chronic ethanol-binge group that wasaccompanied by an increase in protein oxidation of low
and high molecular weight proteins. There was a pre-
dominant increase of protein oxidation of low molecular
weight in chronic ethanol group. Levels of oxidation of
high molecular weight proteins increased in the control-
binge group. In this regard, it may be noted that carbonic
anhydrase levels are far lower in humans and they are
more susceptible to alcoholic liver injury than rats. Inter-
estingly, female rats have far lower CA3 than male rats
and female rats are more susceptible to alcoholic liver in-
jury [38]. Increase in lipid peroxidation was accompanied
by increased expression of CYP2E1 and ethanol induced
CYP2E1 has been implicated in oxidative stress and stea-
tosis [26,27]. However, the magnitude of increase in the
CYP2E1 expression was dramatic in chronic-ethanol
binge compared to chronic ethanol or binge alone. These
findings suggest that chronic ethanol intake sensitizes
liver for ethanol binge induced expression of CYP2E1 to a
greater extent than direct effects of ethanol alone.
Isocitrate dehydrogenase 1 (IDH1) is a NADP-dependent
enzyme that catalyzes the oxidative decarboxylation of iso-
citrate to α-ketoglutarate (α-KG) in the cytoplasm/peroxi-
somes with the concomitant production of NADPH. It is
proposed to play an important role in cellular defense


















Figure 6 Composite images of 2D gels of proteins extracted from liver of control, chronic ethanol, control-binge and chronic ethanol-
binge treated rats. Protein samples (as in Figure 1) were extracted by phenol and methanol/ammonium acetate precipitation and 2D
electrophoresis and Pro Q staining for phospho-protein analysis were performed as described under Material and Methods. Figure represents
pattern of phospho-proteins.
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knock down of IDH1resulted in potentiation of alcohol
induced oxidative stress [40]. Decreased activity of IDH1
by oxidative stress has also been reported in liver [41]. In
the present study, IDH1 was not significantly decreased
after chronic ethanol intake or chronic ethanol-binge.
Glutamine synthetase catalyzes ATP-dependent ami-
dation of glutamate to glutamine. It is responsible for
the intrahepatic and inter tissue ammonia elimination/
detoxification occurring in the liver [42]. Glutamine
synthetase has also been implicated in nucleotide syn-
thesis and amino acid turnover [42]. Glutamine synthe-
tase in normal liver is expressed by a small population
of perivenous hepatocytes [42,43]. Decreased expression
and activity of glutamine synthetase has been considered
to be the sensitive indicator of liver injury and chronic
ethanol intake has been shown to result in decreased glu-
tamine synthetase activity [43,44]. Although, glutamine
synthetase expression is modestly decreased after chronic
ethanol, further decrease occurs after chronic-ethanol
binge but not in control-binge. Decreased protein levels
of glutamine synthetase in liver may contribute to
increased plasma ammonia levels and exaggeration of
central nervous system toxicity.Glutathione S transferase (GST) is a superfamily of
enzymes comprising several isoenzymes. The major GST
subunits expressed in the adult liver are alpha (A1, A2 and
A3) and Mu (M1 and M2). The Pi subunit of GST is only
expressed in fetal hepatocytes, and during early stages of
hepatocarcinogenesis [45]. GST Pi and M forms are drug
metabolizing enzymes and play role in suppressing oxida-
tive stress and reducing the levels of 4-hydroxynonenal
[46]. Chronic ethanol exposure has been shown to cause
both up- and down- regulation of GST M in vivo and in
hepatocytes [46-49]. Accumulation of 4–hydroxynonenal
after chronic ethanol treatment is considered to mediate
liver injury via lipid peroxidation. Therefore, increased ex-
pression of GST that conjugates glutathione to a host of
electrophiles [46] may represent an adaptive response
induced by chronic ethanol. In this regard, GST M null
phenotype has been shown to be associated with increased
susceptibility to alcoholic liver injury [50]. In the present
study, the expression of GST M1 was marginally increased
after chronic ethanol or control ethanol binge, but the
levels did not increase after chronic ethanol- binge suggest-
ing compromised GST M1 after chronic ethanol-binge.
An intriguing finding in the present study is the
change in the levels of different isoforms of PDIA3 in the
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Figure 7 Parameters of liver injury and histology after chronic and chronic ethanol- three binge. Rats were fed ethanol in liquid diet
chronically for 4 weeks and then given 3 binge (5 gm/kg) at 12 hr intervals. Four hours after the last dose, the levels of serum ALT, and hepatic
cleaved caspase-3 were determined as described under Materials and Methods. Sections of liver samples were stained with hematoxylin and
eosin. Control represents pair –fed animals and were given water for binge control. Values are mean± SE (n = 3 rats). Western blot represents a
typical experiment. A-D: Hemotoxylin and eosin staining (x 200X); E: CYP2E1 protein expression. F: 4-HNE immunoblot G: Serum ALT; H: hepatic
cleaved caspase 3; I: H2AX phosphorylation a: significant from control group (p< 0.05); C: Control (pair fed); E: Chronic ethanol; C-B: Control- ethanol
binge; E-B: Chronic-ethanol binge. LMW: low molecular weight; HMW: high molecular weight; Small solid arrow represents leukocyte infiltration.
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ethanol treated or control ethanol binge groups. PDIA3
belongs to the endoplasmic reticular chaperone protein
family of protein disulfide isomerases [51]. These more
negatively charged isoforms arise by either acetylation or
phosphorylation of PDIA3. Recently, increased accumula-
tion of phosphorylated forms of PDIA3 was shown after
angiotensin II stimulation of vascular cells [52] or by pro-
longed fasting in rat liver [23]. Increased carbonylation of
liver PDIA3 has been reported after chronic ethanol treat-
ment in rats and this was accompanied by decreased func-
tion of the isomerase [53]. PDIA3 is emerging as an
important regulator of cell function at multiple levels. It
has been implicated in sorting of glycoproteins, quality
control of endoplasmic reticular proteins, antigen proces-
sing by MHC proteins, control of STAT3 function, induc-
tion of apoptosis, and suppression of steatosis [23,31,54,55].
We have observed increased steatosis and suppressed
apoptosis after chronic ethanol binge (Figure 7) with con-
comitant increases in the levels of PDIA3 acidic isoforms
(Figure 5). Therefore, these results favor the role of PDIA3
in augmentation of liver injury by ethanol binge. Although
suppression of apoptosis is considered as a survival mech-
anism, such phenomenon under the conditions of toxic
insult such as ethanol may be accompanied by disruption
of cell repair mechanisms such as repair of damaged DNA.
DNA damage and impairment of DNA repair have beenreported in animal and human alcoholic liver damage.
Relevantly, knockdown of PDIA3 expression impaired
phosphorylation of H2AX and DNA repair [32]. We have
observed both decreased phosphorylation of H2AX and in-
crease in the levels of acidic isoform of PDIA3 in chronic
ethanol-binge group. It is also known that increase in acidic
(phosphorylated) isoform of PDIA3 is related to decreased
protein folding function of PDIA3 [23]. It is therefore
plausible that in chronic ethanol-binge condition changes
in PDIA3 disrupt protein folding, decrease H2AX phos-
phorylation resulting in a compromised DNA repair.
In summary, chronic ethanol and chronic ethanol
binge display distinct signature profiles of protein ex-
pression. Differential expression of carbonic anhydrase 3,
isocitrate dehydrogenase, glutathione S-transferase, glu-
tamine synthetase, and protein disulfide isomerase pro-
tein 3 accompany increased susceptibility of chronic
ethanol treated rat liver to binge induced injury. The
consequences of these proteomic changes on the amplifi-
cation of alcoholic liver injury by binge ethanol are sche-
matically presented in Figure 8.
Methods
Materials
Male Sprague–Dawley rats (250–300 g) were purchased
from Harlan Laboratories (Indianapolis, IN). ). The anti-
bodies for carbonic anhydrase 3, protein disulfide
BingeChronic
ethanol
Chronic ethanol - binge 
CA3         - - -
CYP2E1 + + +
4-HNE    + +
IDH1         -
GSTM1     + 
GS            -
PDIA3      ++
CYP2E1 +
4-HNE      +
GSTM1     +
IDH1          -
CA3         -
CYP2E1 +
4-HNE     +
GSTM1   +
IDH1        -
Steatosis  +
Necrosis   +
Steatosis  +
Necrosis   +
Inflammation +
Steatosis      ++
Necrosis      ++
Normal liver
Figure 8 A flow diagram showing proteome changes and their relationshsip to liver injury by chronic ethanol binge in the rat model.
This schematic figure depicts that binge, and chronic ethanol have their own effects, but chronic ethanol exposure renders liver more susceptible
to amplification of injury by binge ethanol. The figure shows changes in the levels of CA3, CYP2E1, 4HNE, PDIA3 and other components after
different treatments. Minus (−) and plus (+) symbols indicate the degree of decrease or increase, respectively.
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hydrogenase, and glutamine synthetase were purchased
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA).
Antibodies for histone H2AX and cleaved caspase 3 were
purchased form Cell Signaling (Beverly, MA). CYP2E1
antibody was from AbCam Cambridge, MA. Other
reagents including protease inhibitor cocktail (Sigma
p8340) and β-actin antibody were obtained from the
Sigma-Aldrich (St. Louis, MO).
Animal feeding for chronic ethanol-binge model of
alcoholic liver injury
Rats were housed under a 12-h/12-h light/dark cycle and
were permitted ad libitum consumption of standard la-
boratory rat chow. After a one-week adaptation period,
the animals were fed Lieber–DeCarli liquid diet (Dyets,
Inc., Bethlehem, PA) [20]. Ethanol was progressively
introduced into the liquid diet starting at 1.25% (wt./vol.)
for day 1, increased to 1.67% (wt./vol.) for day 2, to 2.5%
(wt./vol.) for days 3 and 4 and, finally, maintained at 5%
(wt./vol.) for 4 weeks. Weight-matched littermates were
pair-fed on the same liquid diet, except that the ethanolwas replaced by dextrin/maltose (control) to maintain
the isocaloric intake in the two groups. Each day, the
previous day's ethanol diet intake was measured, and the
pair-fed rats were fed same calorie of diet containing
dextrin/maltose. After 4 weeks, rats were divided into
four groups: control, chronic ethanol, control-binge ,
chronic-ethanol binge. Chronic ethanol-binge and con-
trol-binge groups had three doses (each 5 g/kg body wt)
of binge ethanol administered intragastrically every
12 hr. In the control group for chronic ethanol-binge,
ethanol was replaced by water. Liver samples were col-
lected 4 hr after the last binge administration (Aroor et al,
2011), and immediately frozen in liquid nitrogen until fur-
ther use. The animal care and protocol for their use were
approved by the University of Missouri Animal Care &
Use Committee.
Two dimensional electrophoresis
Frozen liver samples were pulverized in liquid nitrogen
using mortar and pestle. Tris-buffered phenol extraction
solution was added to the powdered samples and pro-
teins were extracted using phenol extraction protocol
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Urea, 2 M thiourea, 4% CHAPS, 2% C7BzO, 100 mM
DTT, 2.2% 2-HED). Solubilized samples were quantified
using the EZQ protocol from Life Technologies (Grand
Island, NY). One mg of protein sample was then applied
to 24 cm pH 3–10 IPG strips for passive rehydration
overnight. The IPG strips were isoelectrically focused on
the Protean IEF from Bio-Rad using the following para-
meters: 250 V for 250Vhr (rapid ramp), 1000 V for
500Vhr (rapid ramp), 8000 V for 2 hours (gradient),
8000 V for 80,000Vhr (rapid ramp), and then hold at
500 V. The IPG strips were then placed on 12% SDS-
PAGE gels for the second dimension and ran using the
Ettan Dalt 12 at 1 W/gel overnight. After the run, gels
were stained with Pro-Q diamond stain and imaged
using the Ettan DIGE imager. Gels were then post
stained with Coomassie Brilliant Blue (G250) for the
total protein and scanned using the UMAX powerlook
flatbed scanner. Data were analyzed using Delta 2D sys-
tem from Decodon after normalization. The identifica-
tion of spots that showed distinct differences was based
on aligning and matching of spots in gels and quantifica-
tion of matched spots. The spots were also manually
inspected to verify the accuracy of matching. We
selected a protein spot that showed the least variation
between the samples and this spot was used for
normalization. All the protein spots chosen were present
in all the gels. The results were also analyzed based on
normalization to total spot volume and the pattern was
similar to data analysis based on normalization to the
protein spot with the least variation among the gels. For
phosphoprotein analysis, the values were normalized for
total protein.Analysis of proteins by mass spectrometry
Spots were excised from the gel and subjected to trypsin
digest using a standard in-gel digestion protocol [57].
The extracted peptides were lyophilized and resuspended
in 3 μl of 1% formic acid. A 0.5 μl aliquot of the resulting
peptides was mixed 1:1 with CHCA matrix (5 mg/mL in
60% ACN, 0.3% TFA, 10 mM ammonium phosphate)
and spotted onto the MALDI target. The instrument
(Applied Biosystems 470 Proteomics Analyzer) was oper-
ated in positive ion mode and spectra were acquired over
a mass range of 700 to 4000 Da. Peptide calibration stan-
dards (4700 calibration mix, Applied Biosystems) were
used to calibrate the instrument in MS mode using six
peptides of known mass. Calibration was achieved by the
“plate model and default” mode for MS of six external
calibrant spots. Additionally, internal (i.e. within the
sample spot) calibration was achieved using trypsin au-
tolysis peptides (where present). Note: although trypsin
autolysis ions are useful for obtaining the best massaccuracy, these ions are automatically excluded from the
database search conducted using the GPS Explorer.
Following an MS scan of each sample the 8 most abun-
dant peptides were picked automatically for tandem MS
(MSMS – peptide fragmentation) acquisition. Following
this a database search was performed using V3.6 of GPS
Explorer. Ions with s/n ratios >20 (excluding trypsin au-
tolysis) up to a max of 125 per spectrum were submitted
for searches against mammal entries in the NCBInr data-
base (last updated September 9th 2010) using the “com-
bined MS+MSMS” function of the GPS Explorer
software. The GPS Explorer software is integrated with
the MASCOT V2.2 (www.matrixscience.com). Search
parameters allowed: 1 trypsin miss-cleavage and the fol-
lowing modifications to peptides: carbamidomethyl
cysteines, and methionine oxidation. MS mass tolerance
was 100 ppm, MSMS mass tolerance was 0.2 Da.
Liquid Chromatography Tandem Mass Spectrometry
analysis: Digests were diluted to 5 μl with 1% formic acid
and transferred to an autosampler vial and placed in the
autosampler which was maintained at 4°C. A portion of
the sample (3 μL) was loaded onto a 150 mm C18 CHIP
(Agilent Technologies cat# G4240-62002). Peptides were
separated and eluted from the analytical column with a
continuous gradient of acetonitrile from 3 to 45% (in
0.1% formic acid) over 8 minutes. Following an MS scan
of the eluting peptides, each cycle, the five most abun-
dant peptides were subjected to peptide fragmentation
(MSMS). Data across 17 minutes were collected. MSMS
data were extracted and a peak list file (mgf – mascot
generic format file) was generated using the qualitative
analysis software. A search of NCBInr-limited to mam-
mals was conducted using a local copy of MASCOT
server V2.2. We selected only eight proteins by proteome
analysis. The use of Coomassie blue staining and use of
broader pH range might have resulted in the detection
of lower number of spots. Our objective was to cover
wide range of proteins and obtain adequate amount of
protein for mass spectrometry analysis. Therefore, we
have adopted this protocol. The limited number spot dif-
ference has also been reported for other proteome studies
in chronic ethanol administration and endotoxin induced
liver injury [19,58].Statistical analysis
Data are expressed as means±S.E.M. Statistical significance
of the differences between means was assessed by Student's
t test. A probability of less than 5% was considered signifi-
cant (P< 0.05).Abbreviations
ALT: Alanine transaminase; CA3: Carbonic anhydrase 3; CBB: Coomassie
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